Clinical Trials
Braintumor Website

There are 9 trials:
Facility: Primary Children's Hospital
NCT Trial Name# of Centers

NCT00898079

  Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
167

NCT00736749

  Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
141

NCT01217437

  Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
138

NCT00437060

  Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
106

NCT01553149

  Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
76

NCT01960075

  Established Status Epilepticus Treatment Trial
49

NCT02162732

  Molecular-Guided Therapy for Childhood Cancer
17

NCT00601003

  Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
15

NCT01802567

  Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer
11



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites